Early trial tests 'Off-the-Shelf' cell therapy for tough lymphoma cases
NCT ID NCT07248163
Summary
This early-stage study is testing a new type of cell therapy called universal CAR-T for adults with B-cell non-Hodgkin lymphoma that has returned or not responded to other treatments. Doctors will give a single dose of these specially engineered immune cells to 3-6 patients to check if it's safe and if it helps fight the cancer. The goal is to see if this 'off-the-shelf' approach can control the disease in patients who have few other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA,B CELL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Shanghi Tongji Hospital (Tongji Hospital of Tongji University)
RECRUITINGShanghai, 620000, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.